Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001078782-19-000800
Filing Date
2019-10-30
Accepted
2019-10-29 20:35:17
Documents
42
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A AMENDED ANNUAL REPORT 10ka123118_10kz.htm 10-K/A 70761
2 EXHIBIT 10.4 LETTER OF INTENT (TERMS SHEET) DATED SEPTEMBER 3, 2018, BY AND BETW f10ka123118_ex10z4.htm EX-10.4 1712
3 EXHIBIT 10.5 EXCLUSIVITY AGREEMENT DATED SEPTEMBER 3, 2018, BY AND BETWEEN IMPRE f10ka123118_ex10z5.htm EX-10.5 1386
4 EXHIBIT 10.6 AMENDMENT #1 TO EXCLUSIVITY AGREEMENT DATED DECEMBER 11, 2018, BY A f10ka123118_ex10z6.htm EX-10.6 816
5 EXHIBIT 10.7 SUPPLY AGREEMENT DATED MAY 31, 2019, BY AND BETWEEN IMPRESSION HEAL f10ka123118_ex10z7.htm EX-10.7 7603
6 EXHIBIT 31.1 SECTION 302 CERTIFICATION f10ka123118_ex31z1.htm EX-31.1 8232
7 EXHIBIT 31.2 SECTION 302 CERTIFICATION f10ka123118_ex31z2.htm EX-31.2 8940
8 EXHIBIT 32.1 SECTION 906 CERTIFICATION f10ka123118_ex32z1.htm EX-32.1 3379
9 EXHIBIT 32.2 SECTION 906 CERTIFICATION f10ka123118_ex32z2.htm EX-32.2 3040
10 IMAGE f10ka12311810kz1.jpg GRAPHIC 31977
11 IMAGE f10ka123118ex10z41.jpg GRAPHIC 436258
12 IMAGE f10ka123118ex10z42.jpg GRAPHIC 546471
13 IMAGE f10ka123118ex10z43.jpg GRAPHIC 269493
14 IMAGE f10ka123118ex10z44.jpg GRAPHIC 198429
15 IMAGE f10ka123118ex10z51.jpg GRAPHIC 438167
16 IMAGE f10ka123118ex10z52.jpg GRAPHIC 408591
17 IMAGE f10ka123118ex10z53.jpg GRAPHIC 201359
18 IMAGE f10ka123118ex10z61.jpg GRAPHIC 432215
19 IMAGE f10ka123118ex10z71.jpg GRAPHIC 333280
20 IMAGE f10ka123118ex10z72.jpg GRAPHIC 247125
21 IMAGE f10ka123118ex10z73.jpg GRAPHIC 736590
22 IMAGE f10ka123118ex10z74.jpg GRAPHIC 843088
23 IMAGE f10ka123118ex10z75.jpg GRAPHIC 623002
24 IMAGE f10ka123118ex10z76.jpg GRAPHIC 650127
25 IMAGE f10ka123118ex10z77.jpg GRAPHIC 589992
26 IMAGE f10ka123118ex10z78.jpg GRAPHIC 738775
27 IMAGE f10ka123118ex10z79.jpg GRAPHIC 661982
28 IMAGE f10ka123118ex10z710.jpg GRAPHIC 534016
29 IMAGE f10ka123118ex10z711.jpg GRAPHIC 671213
30 IMAGE f10ka123118ex10z712.jpg GRAPHIC 648524
31 IMAGE f10ka123118ex10z713.jpg GRAPHIC 669121
32 IMAGE f10ka123118ex10z714.jpg GRAPHIC 643744
33 IMAGE f10ka123118ex10z715.jpg GRAPHIC 634547
34 IMAGE f10ka123118ex10z716.jpg GRAPHIC 603574
35 IMAGE f10ka123118ex10z717.jpg GRAPHIC 582738
36 IMAGE f10ka123118ex10z718.jpg GRAPHIC 560555
37 IMAGE f10ka123118ex10z719.jpg GRAPHIC 545373
38 IMAGE f10ka123118ex10z720.jpg GRAPHIC 89549
39 IMAGE f10ka123118ex10z721.jpg GRAPHIC 88309
40 IMAGE f10ka123118ex10z722.jpg GRAPHIC 481652
41 IMAGE f10ka123118ex10z723.jpg GRAPHIC 134157
42 IMAGE f10ka123118ex10z724.jpg GRAPHIC 192042
  Complete submission text file 0001078782-19-000800.txt   21411797
Mailing Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022
Business Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

EIN.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-54296 | Film No.: 191177142
SIC: 2834 Pharmaceutical Preparations